Leukoregulin upregulation of prostaglandin endoperoxide H synthase-2 expression in human orbital fibroblasts

Human orbital fibroblasts from patients with severe thyroid-associated ophthalmopathy are particularly susceptible to the actions of a variety of proinflammatory molecules. In this study, we demonstrate that the inductions of prostaglandin endoperoxide H synthase-2 (PGHS-2), interleukin (IL)-1alpha, and IL-1beta by leukoregulin, a product of activated T lymphocytes, are far more robust in orbital fibroblasts than those observed in dermal fibroblasts. These actions of leukoregulin are mediated through an intermediate induction of IL-1alpha. In contrast, leukoregulin also induces IL-1-receptor antagonist (IL-1ra) expression in orbital fibroblasts, but this induction is considerably greater in dermal fibroblasts (2.3- vs. 8.5-fold). Interrupting the effects of IL-1alpha, either with a neutralizing antibody or with exogenous IL-1ra, can block the induction of PGHS-2 by leukoregulin. Leukoregulin increases PGHS-2 gene transcription in orbital fibroblasts but exerts the major effect on cyclooxygenase expression by enhancing the stability of mature PGHS-2 mRNA. The cytokine triggers nuclear translocation of nuclear factor-kappaB (NF-kappaB) p50/p50 homodimers and p50/p65 heterodimers, and an inhibitor of this transcriptional factor, pyrrolidinedithiocarbamate, can attenuate the PGHS-2 induction. Thus differential inducibility of the members of the IL-1 family of genes in orbital fibroblasts would appear to underlie, at least in part, the differences in PGHS-2 induction observed in orbital and dermal fibroblasts. NF-kappaB plays an important role in mediating the effects of leukoregulin on PGHS-2 expression.

Medienart:

E-Artikel

Erscheinungsjahr:

1999

Erschienen:

1999

Enthalten in:

Zur Gesamtaufnahme - volume:277

Enthalten in:

The American journal of physiology - 277(1999), 6 vom: 17. Dez., Seite C1075-85

Sprache:

Englisch

Beteiligte Personen:

Cao, H J [VerfasserIn]
Smith, T J [VerfasserIn]

Links:

Volltext

Themen:

7S5I7G3JQL
Anti-Inflammatory Agents
Antibodies
Antineoplastic Agents, Hormonal
Cyclooxygenase 2
Dexamethasone
Dinoprostone
EC 1.14.99.1
IL1RN protein, human
Interleukin 1 Receptor Antagonist Protein
Interleukin-1
Isoenzymes
Journal Article
K7Q1JQR04M
Leukoregulin
Lymphokines
Membrane Proteins
NF-kappa B
PTGS2 protein, human
Prostaglandin-Endoperoxide Synthases
RNA, Messenger
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.
Sialoglycoproteins

Anmerkungen:

Date Completed 20.01.2000

Date Revised 20.09.2018

published: Print

Citation Status MEDLINE

doi:

10.1152/ajpcell.1999.277.6.C1075

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM105305472